A multicenter survey on access to care in Multiple Sclerosis-related trigeminal neuralgia.


Journal

Journal of the neurological sciences
ISSN: 1878-5883
Titre abrégé: J Neurol Sci
Pays: Netherlands
ID NLM: 0375403

Informations de publication

Date de publication:
15 05 2021
Historique:
received: 18 01 2021
revised: 17 03 2021
accepted: 25 03 2021
pubmed: 11 4 2021
medline: 15 5 2021
entrez: 10 4 2021
Statut: ppublish

Résumé

The prevalence of trigeminal neuralgia (TN) in patients with Multiple Sclerosis (MS) is higher than in the general population and its management can be particularly challenging due to a number of reasons including high recurrence rates, lack of MS-specific treatment guidelines and uncertainties about pain pathophysiology. Aim of this cross-sectional, multicentre survey was to gather information on the current treatment modalities and options of MS-related TN across 23 Italian MS centres. Initial medical management (carbamazepine or oxcarbazepine) of MS-related TN was fairly homogeneous throughout Italian centres. The most commonly available surgical procedure was microvascular decompression, but the frequency and types of surgical procedures available locally differed considerably throughout MS centers, and were unavailable in one quarter of them. This survey reveals some of the issues that could hamper an optimal patient management and underlines the need for a consensus on MS-related TN to support health-care professionals in their approach to this challenging condition and to facilitate the development of local guidelines aimed at ensuring equity in access to care and treatment optimization.

Identifiants

pubmed: 33838554
pii: S0022-510X(21)00123-4
doi: 10.1016/j.jns.2021.117430
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

117430

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

D Ferraro (D)

Department of Biomedical, Metabolic and Neurosciences, University of Modena and Reggio Emilia, Modena, Italy. Electronic address: diana.ferraro@unimore.it.

P Annovazzi (P)

MS Center, ASST Valle Olona, Gallarate Hospital, Varese, Italy.

R Lanzillo (R)

MS Clinical Care and Research Centre, Department of Neuroscience, Federico II University of Naples, Naples, Italy.

M Calabrese (M)

Department of Neuroscience, Biomedicine and Movement, University Hospital of Verona, Verona, Italy.

R Fantozzi (R)

Neurology Unit, IRCCS Neuromed, Pozzilli (IS), Italy.

G De Luca (G)

MS Centre, Neurology Unit, SS. Annunziata University Hospital, Chieti, Italy.

C Cordioli (C)

Multiple Sclerosis Center, ASST Spedali Civili di Brescia, Montichiari (Brescia), Italy.

D Paolicelli (D)

Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Bari, Italy.

P Ragonese (P)

Department of Biomedicine Neurosciences and advanced Diagnostic (BiND), University of Palermo, Palermo, Italy.

A Gajofatto (A)

Department of Neuroscience, Biomedicine and Movement, University Hospital of Verona, Verona, Italy.

S Lo Fermo (S)

MS Center, A.O.U. "Policlinico-Vittorio Emanuele", Catania, Italy.

P Cavalla (P)

Department of Neurosciences and Mental Health, AOU City of Health & Science University Hospital, Turin, Italy.

C Tortorella (C)

Department of Neurosciences, San Camillo Hospital, Rome, Italy.

I Pesci (I)

Neurology Unit, Vaio Hospital, Fidenza (PR), Italy.

A Gallo (A)

Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, Campania University "L. Vanvitelli", Naples, Italy.

F Pinardi (F)

UOSI Multiple Sclerosis Rehabilitation, IRCCS, Bologna, Italy.

M Di Filippo (M)

Neurology Unit, Medicine Department, University of Perugia, Perugia, Italy.

G T Maniscalco (GT)

Neurology Unit, A. Cardarelli Hospital, Naples, Italy.

V Nociti (V)

Institute of Neurology, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS and Catholic University, Rome, Italy.

M Radaelli (M)

Multiple Sclerosis Center, Ospedale Papa Giovanni XIII, Bergamo, Italy.

V Tomassini (V)

MS Centre, Neurology Unit, SS. Annunziata University Hospital, Chieti, Italy; Department of Neurosciences, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, Chieti, Italy.

M C Buscarinu (MC)

Department of Neurosciences, Mental Health and Sensory Organs, Sapienza University, Rome, Italy.

M Moccia (M)

MS Clinical Care and Research Centre, Department of Neuroscience, Federico II University of Naples, Naples, Italy.

V Camera (V)

Department of Biomedical, Metabolic and Neurosciences, University of Modena and Reggio Emilia, Modena, Italy.

E Cocco (E)

Department of Medical Sciences and Public Health,University of Cagliari, Cagliari, Italy.

C Gasperini (C)

Department of Neurosciences, San Camillo Hospital, Rome, Italy.

C Solaro (C)

Rehabilitation Department, Mons. L. Novarese, Moncrivello, Vercelli, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH